Your session is about to expire
← Back to Search
Treadmill Training for Parkinson's Disease
Study Summary
This trial will explore if controlling both speed and cadence during treadmill training may elicit more benefits than controlling speed alone in individuals with Parkinson's disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowExclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You can walk by yourself for more than 15 meters without help.You have a heart, lung, or metabolic condition that is not being properly controlled.You have injured your leg in the last 6 months.You have any other known brain or nerve conditions that affect your ability to walk.You can walk on a treadmill by yourself for at least 15 minutes.You have any problems with your vision or speaking.
- Group 1: Advanced Training Group
- Group 2: Traditional Training Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 1 Days to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 1 null
- Follow Ups: You may be asked to continue sharing information regarding the trial for 0 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there capacity for more volunteers to join this clinical experiment?
"Affirmative. Clinicaltrials.gov indicates that recruitment for this study is currently taking place, with the initial posting occuring on March 21st 2022 and last update made April 16th of that same year. 20 participants are being sourced from a single trial site."
What is the total participant quota for this experiment?
"Affirmative. According to the data hosted on clinicaltrials.gov, this medical study is actively looking for candidates; it was first posted on March 21st 2022 and has been recently updated on April 16th of that same year. The trial requires 20 participants at one site in particular."
Does this research trial accept participants of at least 25 years of age?
"The specified age range for this trial is 18 to 89, with those under the age of majority being eligible."
Who meets the criteria to partake in this experiment?
"This medical research requires the enrolment of 20 participants diagnosed with Parkinson's disease. The age range is 18 to 89, and all must be able to read English fluently. Additionally, each should fall within stages 1-3 according Hoehn and Yahr scale for PD motor impairment evaluation, as well as being independent walkers capable of ambulating 15m or more overground and enduring a treadmill session lasting at least quarter of an hour."
Share this study with friends
Copy Link
Messenger